Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.

Source:http://linkedlifedata.com/resource/pubmed/id/18172605

Download in:

View as

General Info

PMID
18172605